𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The patterns of extrainsular endocrine cells in pancreatic cancer

✍ Scribed by Bruno M. Schmied; Alexis B. Ulrich; Helmut Friess; Markus W. Büchler; Parviz M. Pour

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
249 KB
Volume
21
Category
Article
ISSN
0270-3211

No coin nor oath required. For personal study only.

✦ Synopsis

Abnormal glucose tolerance and frank diabetes mellitus develop in up to 80% of pancreatic cancer patients. Islets within these tumors show a decreased number of beta cells and increased number of alpha cells. The reduced number of beta cells could induce beta cell neogenesis in extrainsular tissue to compensate for the loss of insulin in islets. On the other hand, because the beta cell depletion in pancreatic cancer seems to be the effect of substances released by cancer cells, suppression of extrainsular endocrine cells is expected. We compared the pattern of extrainsular endocrine cells in pancreatic cancer patients with normal pancreas as well as chronic pancreatitis, which is known to be associated with impaired glucose tolerance or frank diabetes. As in the normal tissue, extrainsular endocrine cells were found in chronic pancreatitis and pancreatic cancer. However, in the chronic pancreatitis specimens insulin cells were the predominant cell type, whereas in pancreatic cancer specimens more glucagon than insulin cells were found, although the differences were statistically insignificant. Thus, our results indicate that the alteration of beta cells in pancreatic cancer patients is mainly restricted to the endocrine cells within the islets and that there is no compensatory proliferation of beta cells.

📜 SIMILAR VOLUMES

Patterns of genetic alterations in pancr
Patterns of genetic alterations in pancreatic cancer: A pooled analysis
✍ Heidi Michels Blanck; Paige E. Tolbert; Jane A. Hoppin 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

Both K-ras and p53 gene mutations are found commonly in pancreatic tumors. Analysis of the mutational patterns may provide insight into disease etiology. To further describe the mutational patterns of pancreatic cancer and to assess the evidence to date, we performed a pooled analysis of the publish

Gefitinib Inhibits the Proliferation of
Gefitinib Inhibits the Proliferation of Pancreatic Cancer Cells via Cell Cycle Arrest
✍ Xiaohua Zhou; Maqing Zheng; Fang Chen; Yunxia Zhu; Wei Yong; Haiyan Lin; Yujie S 📂 Article 📅 2009 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 281 KB 👁 1 views

## Abstract High expression of the epidermal growth factor receptor (EGFR) has been implicated in the development of pancreatic cancer. Gefitinib is an orally active and selective EGFR‐TKI (EGFR‐tyrosine kinase inhibitor) that blocks signal transduction pathways responsible for the proliferation an

Involvement of adhesion molecules in met
Involvement of adhesion molecules in metastasis of SW1990, human pancreatic cancer cells
✍ Hosono, Jiro; Narita, Tatsuhiko; Kimura, Naoko; Sato, Mikinori; Nakashio, Tatsua 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB 👁 2 views

## Background and objective: Peritoneal dissemination and hepatic metastasis commonly occur after patients with pancreatic cancer have undergone surgery. it is thought that specific adhesion molecules play corresponding roles in cancer metastasis. ## Study design/materials and methods: We conduct

Experimental method for the hyperthermic
Experimental method for the hyperthermic treatment of cells in tissue culture: Initial application to pancreatic cancer cells
✍ Barbara K. Chang; William T. Joines; Judith A. Gregory 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 462 KB 👁 2 views

Hyperthermia is attractive as a potential adjunctive modality in the treatment of cancer, especially those cancers that are more resistant to conventional modalities. In the present study, we characterized the response of two pancreatic cancer cell lines to hyperthermia alone. In so doing, we utiliz

Carcinoembryonic antigen (CEA) in the di
Carcinoembryonic antigen (CEA) in the diagnosis of pancreatic cancer
✍ F. V. Ona; N. Zamcheck; P. Dhar; T. Moore; H. Z. Kupchik 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB 👁 2 views

Twenty-three (85%) of 27 patients with pancreatic cancer tested for CEA by the method of Gold were positive. The CEA assay was more frequently positive in patients with cancer of the pancreas than were any other diagnostic tests used, including upper gastrointestinal series,g hypotonic duodenography